*By Conor White* The Curiosity rover is no longer alone on Mars. NASA's InSight lander successfully touched down on the Red Planet Monday afternoon, but spectators will have months to wait before any results arrive. "It's a 26-month mission," said Sarah Lewin, an associate editor at Space.com said. The first results from InSight's experiments are expected sometime in the spring. InSight marks NASA's first mission to Mars since Curiosity began its journey in 2011. The launch was originally scheduled for 2016 before officials discovered a leak in the rocket's vacuum chamber. As a result, InSight missed its launch window. The delay and necessary repairs added almost $154 million to the mission's price tag, bringing it to a total cost of $814 million. And even those years of planning didn't guarantee a success. "Mars missions have like a 40 percent success rate across the world," Lewin said. "NASA is a little bit higher, so there was a definite chance it wouldn't work." Now that it has safely landed, the probe will be responsible for drilling into Mars ー largely to determine the planet's composition. The robot will also monitor the planet for "Marsquakes." "We've put a lot of things on Mars that are either orbiters, which are looking down on it, or rovers like Curiosity exploring the surface, but we really don't know what's going on inside," Lewin said.

Share:
More In Science
Fears Ukraine War Could Lead to Rise in COVID-19, Other Infectious Diseases
As the Russia's invasion of Ukraine continues, medical experts are worried conditions in active warzones will exacerbate the current pandemic — or even give rise to other contagions. Dr. Daniel Fagbuyi, a war veteran and former Obama administration biodefense appointee, joined Cheddar News to discuss the ongoing danger of COVID-19 on top of the war, as well as the potential for new variants to emerge. "I mean just large volumes of people definitely is a breeding ground. That's the worst case," he said. "Two things don't mix: war-conflict and a virus, a potential pandemic virus."
Medical Cannabis Company Akanda Sees Stock Surge in March's First IPO
Medical cannabis company Akanda went public this week in what was the first traditional IPO of the month. Shares jumped about 163% in the stock's first day of trading. The London-based company says it hopes to supply medical cannabis products to wholesalers in international markets. Tej Virk, CEO of Akanda, joins Cheddar News' Closing Bell to discuss.
Colossal CEO Says Its About Saving Biodiversity, Not Just Extinct Woolly Mammoth
Bioscience and genetic engineering company, Colossal, raised $60 million in a Series A funding round. Colossal is focused on developing new technologies and genetic tools to restore extinct species, and protect critically endangered species. One of the startup's long-term goals is to resurrect the woolly mammoth, and return it back to the arctic. Colossal also says it is developing technology that expands beyond animals, and has the potential to advance human health. Ben Lamm, co-founder and CEO of Colossal, joins Cheddar News' Closing Bell to discuss.
Reflecting On The Healthcare Industry Two Years Into The Pandemic
Two years into the pandemic, many of us have regained a sense of normalcy. However, those in the healthcare industry are still confronting the virus every day, dealing with the physical, mental and psychological stress of the ongoing pandemic. Ben Mirtes, CFO of Ingenovis Health and Lydia Mobley, a travel nurse with Faststaff, who has spent the last two years going from hotspot to hotspot, joined Cheddar’s Opening Bell to reflect on their experiences in healthcare, and discuss why they are optimistic about a path forward.
Need2Know: Ukraine Updates, Disney Walkout & NASA spacewalk
Catching you up on what you Need to Know on March 16, 2022, with updates on Ukraine and Russia, a container ship gets stuck in the Chesapeake Bay, Disney employees stage a walkout over the "Don't Say Gay" law in Florida, and NASA completes its first spacewalk of 2022.
Food Technology Company Tender Food Raises $12 Million to Make Alternative Meats With Authentic Texture
Food technology startup Tender Food raised $12 million in a seed round led by Chris Sacca's Lowercarbon Capital. Tender says it specializes in creating alternative meats with an authentic texture and is on a mission to make alternative meats so delicious, nutritious, and affordable, that eating meat from animals will no longer make sense. Christophe Chantre, co-founder & CEO of Tender Food, joins Cheddar News' Closing Bell to discuss.
Load More